a routine clinical procedure to identify pathogenic variants responsible for a patient's
phenotype. Exome sequencing has the capability of reliably identifying inherited and de
novo single-nucleotide variants, small insertions, and deletions. However, due to the use of
100–300-bp fragment reads, this platform is not well powered to sensitively identify
moderate to large structural variants (SV), such as insertions, deletions, inversions, and …